Regulations.gov document
Determination That XYLOCAINE (Lidocaine Hydrochloride) Topical Solution 4%, Was Not…
Notice · FDA-2021-P-1248 · posted Jul 21, 2022
Key facts
| Document ID | FDA-2021-P-1248-0006 |
|---|---|
| Title | Determination That XYLOCAINE (Lidocaine Hydrochloride) Topical Solution 4%, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness |
| Document type | Notice |
| Subtype | General Notice |
| Agency | FDA |
| Docket | FDA-2021-P-1248 |
| Posted | Jul 21, 2022 |
| Federal Register citation | FR 87 43533 |
| FR document number | 2022-15594 |
| Effective date | Jul 21, 2022 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: